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S
Objectives . 'file aim of this study was to report the results and
techniques of radiofrequency ablution for treatment of sttpraven-
tricular atrrhythardns in patients with congenital structural heart
disease .
Background. "rite s anogemeut of patients with congenial and
other structural heart disease may be complicated by serious
arrhythmias due to Wolff-Parkinson .White syndrome or by a trial
arrhythmias after cardiac surgery . Ablation techatitlaes using
radiofrequency current are revolutionizing the management of
arrhythmias, but reports have included few with structural heart
disease .
Methods . Fifteen patients with significant heart disease under-
went radiofrequency ablation : 11 with Wolf-Parkinson-White
syndrome and 4 with intrantrial reentrant tachycardia after atrial
surgery. Seven had Ebstein's ano aly, complex in two, and the
rest had other defects. Coexistence of structural defects intro-
duced significant technical difficulties to radiofrequency ablation
in patients with the Wolf Parkinson-White syndrome and was
otccomplished by adaptation of current techniques . Ablation of
Cardiac arrhythmias may complicate the management of
patients with congenital structural heart disease . In the
setting of impaired or marginal hemodynamic conditions,
arrhythmias may be poorly tolerated, as may antiarrhythmic
agents . The latter may impair myocardial function, worsen
sinus node dysfunction or be proarrhythmic. Consequently,
the use of ablation techniques may be indicated in some of
these patients . Radiofrequency energy has been used for
transcatheter ablation of ac,;essory pathways (1-4), for
atrioventricular (AV) node modification in AV node reen-
trant tachycardia (2,5) and for treating arrhythmias in chil-
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iutraaatriaal reentrant tetycardia was performed by finding early
atrial activation sites with electrogram fractionation for radio-
frequent-y application .
Results . Radiofrequency ablation was initially successful in 14
of 15 patients, with cure in 10 and clinical improvement in 14 .
Two patients subsequently underwent cardiac surgery with t
p-erkoperative arrhythmias .
Conclusions . ltadiofrequency ablation in patients with congen .
ital heart disease and arrhythmias is both safe and effective nod
may be the preferred approach to treatment in some patients .
patients who are to undergo surgical correction or palliation,
preoperative radiofrequency ablation of the tachycardia substrate
is effective and may be preferred to operative accessory pathway
division . The ablation of intraatrial reentrant tachycardia shows
promise in the management of patients who have undergone
extensive atrial surgery, and it may eventually become the pre.
ferred approach, particularly when there are contraindications to
the use of antiarrhythmic agents .
(J Am Cog Cardiol 1993:883-90)
dren (6- 11) . However, there is scant information on the
success of this technique in patients with congenital heart
disease . We report here our experience with radiofrequency
ablation for the treatment of several types of supraventricu-
lar tachycardia in children and adults with congenital cardiac
disease .
Methods
Study patients . The patients included in this study were
referred to our institution for management of recurrent
tachycardia and were known to have congenital heart dis-
ease. Patients selected for radiofrequency ablation proce-
dures either were known to be refractory to antiarrhythmic
agents or were to undergo surgical correction or palliation of
a congenital cardiac abnormality . All patients underwent an
initial evaluation that included history, physical
examina-
tion, electrocardiogram (ECG) and echocardiogram
with
color Doppler flow mapping to carefully delineate intracar-
diac anatomy
. With intravenous sedation, an electrophysio-
logic study was performed for definition of arrhythmia
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mechanism and for intracardiac mapping using previously
described methods (7,12) .
In patients to be referred for
surgical management of structural cardiac disease, a hemo-
dynamic and angiographic study was also performed .
Study protocol. The diagnosis of accessory pathways was
made by standard criteria
. When the, diagnosis of a reentrant
atrial tachyarrhythmia was established, atrial flutter and
intraatrial reentrant tachycardia were distinguished from
each other as follows : Atrial flutter was diagnosed if there
were clear flutter waves on the surface ECG and the atrial
cycle length was %240 ms. Intraatrial reentrant tachycardia
was diagnosed if discrete P waves were present, with an
atrial cycle length >240 ms .
The protocol was approved by the Committee on Human
Research, and written informed patient consent was ob-
tained for the procedure . Patients 1, 3, 4 and 6 have been
previously reported as part of an inclusive series of all
patients undergoing catheter ablation at our instutution
(7,12) .
After localization of arrhythmia substrates and anticoag-
ulation with approximately 100 U/kg of intravenous heparin,
radiofrequency lesions were created using a 7F or 6F tip-
deflecting catheter with a large (4 mm) distal electrode
(Mansfield Scientific, Mansfield, MA or EP Technologies) .
Radiofrequency current was supplied using a radiofrequency
lesion generator (model RFG3B, Radionics Corp . or EP
Technologies), which supplied up to 50 W of continuous,
unmoe4i4ted current at 500 kHz delivered between 1he distal
pole of the ablation catheter and a large surface area skin
electrode. If a sudden rise in telemetered voltage and fall in
current occurred indicating a rise in impedance, application
of energy was immediately discontinued, the catheter re-
moved and the distal electrode cleaned before reintroduc-
tion . Otherwise, energy was delivered for up to 100 s at each
site .
Ablation of accessory pathways . As previously reported
(7,12), accessory pathway location was carefully mapped
using the ablation catheter. The site of earliest ventricular
activation along the AV ring was determined during sinus
rhythm, as well as the site of earliest retrograde atrial
activation during supraventricular tachycardia . In some pa-
tients, mapping of the right AV ring was performed using an
intracoronary mapping wire (13,14), The catheter was posi-
tioned against the AV ring on the atrial or ventricular side,
and fluoroselopic evidence of concordant movement of the
ablation catheter with the plane of the AV valve was seen,
documenting good tissue contact . OP' signals were re-
corded from these sites that were pot) phasic and continu-
ous, suggesting the presence of accessory pathway ("Kent")
potentials . Radiofrequ ;ettcy lesions were made at these sites,
with attesting to document lack of accessory pathway func-
tion I h after the last lesion .
Slow pathway ablation for atrioventricular node reentry .
Stow pathway ablation was performed by the method de-
scribed by Jackman et al . (15) . Radiofrequency lesions were
placed in the posterior septum close to or inside the mouth of
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the coronary sinus at sites with a large ventricular and a
small atrial electrogram in sinus rhythm . Retesting was
performed both with and without isoproterenol infusion to
document lack of arrhythmia inducibility and loss of slow
pathway function .
Intrawrial reentrant tachycardia . The diagnosis of in-
traatrial reentrant tachycardia was confirmed electrophysio-
logically by noting 1) an intraatrial activation sequence not
consistent with retrograde atrial activation from the AV
node; 2) induction and termination of tachycardia by single
premature atrial contractions ; and 3) the continuation of
tachycardia despite AV block, either spontaneous or in-
duced by the administration of adenosine intravenously .
Multiple intramial electrode catheters were placed . Initial
mapping involved localization of earliest atrial activation
during tachycardia in relation to the onset of the P wave on
the surface I3CG . Further localization was accomplished by
pacing from candidate sites during shius rhythm at the
fachycardia cycle length in an attempt to reproduce both the
P wave axis and configuration on the 12-lead ECG, as well as
the intr=,rdiac activation sequence recorded from intraca .-
diac catheters that was seen during tachycardia. During
tachycardia, areas of atria" clectrograin fractionation were
sought near the regions of early activation
. A fractionated
electrogram was defined as an electrogram that was qualita-
tively more poilyphasic than other electrograms obtained
locally (16). short test lesions were then administered to
these sites a! fractionation 6ring tachycardia, and lesions
that resulted in immediate tachycardia termination were
continued for 100 s . Aggressive testing for inducibility was
then performed and was repeated I h after the last lesion .
This testing included the administration of isoproterenol .
,Follow-up study
. Echocardiograms were obtained on the
day after the ablation procedure . Ambulatory 24-1h ECGs
were obtained on the day after the procedure and again at
approximately I month after the procedure . Follow-up clec-
trophysiologic studies were not routinely recommended in
asymptomatic patients, but all patients were followed with
periodic standard and 24-h ECGs. For success rates, 95%
confidence intervals were calculated by the second method
of Armitage (17) .
Results
Fifteen patients with congenital heart disease underwent
radiofrequency catheter ablation . They will be considered in
two groups: those with a congenital substrate for arrhythmia
(Group 1) and those with an acquired substrate (Group 2) .
All I I patients in Group I had the Wolf Parkinson-White
syndrome, and 2 of these also had dual AV node pathways .
All four patients in Group 2 had previously undergone
cardiac surgery and had intraatrial reentrant tachycardia,
and one of these also had AV node reentry .
The median age at time of ablation was 15 years (range 15
months to 61 years) . One ablation proceelire was performed
in 11 patients, and two sessions were necessary in 4
. The
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Figure 1 . Patient 3. A, Two-dimensional echocardiogram, apical
four-chamber view, showing severe inferior displacement of the
tricuspid annulus, right ventricular hypoplasia and a left ventricular
diverticulum . AV = atrioventricular ; LA = left atrium; LV = left
ventricle ; RA = right atrium; RV = right ventricle. B, Fluoroscopic
studies in Patient 3 . Left panel, Right coronary angiogram, slight left
anterior oblique projection . Right panel, Right anterior oblique
projection . The right coronary artery is cannulated with a custom
mapping wire introduced through a right coronary angiographic
catheter and the ablation catheter is positioned toward the tip of the
mapping catheter .
average total duration of fluoroscopy was 81 .8 min (range
33.2 to 144 [unavailable in two patients]) and the average
duration of the procedures was 219 min (range 126 to 325)
after introduction of the catheters . Ablation required a
median of 22 applications of radiofrequency energy (range
4 to 30) . Overall, 10 of 15 patients had complete elimination
of tachycardia (67%, 95% confidence interval [0], 42% to
85%), and 14 of 15 had clinical improvement (93%, 95% CI
70% to 99%) (17) . No major or minor complications occurred
as a result of either the electrophysiologic study or the
ablation procedure .
Group I
Patients. Eleven patients with the Wolff-Parkinson-
White syndrome and significant congenital heart disease had
ablation of accessory pathways . Moderate Ebstein's anom.,
aly was present in four patients, severe Ebstein's anomaly
with associated problems in three (Fig . 1) and other diag-
VAN HARE ET AL
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noses were present in four (Table I) . Even brief tachycardia
was very poorly tolerated hemodynainically in Patients 2, 3,
4 and I I because of the coexisting structural heart disease .
In three patients ablation was performed as preparation for
surgical correction or palliation of serious congenital heart
disease (Patients I to 3). In each case the planned surgical
procedure involved cardiopulmonary bypass, and it was
believed that the additional time for intraoperative accessory
ry
pathway ablation by the endocardial approach would
significantly prolong the time on cardiopulmonary bypass,
thereby increasing the risks of the procedure .
Results. Fifteen accessor, , pathways were found in I I
patients, and 13 of 15 pathways were successfully ablated in
15 ablation sessions (2 sessions in each of 4 patients) . In
Patient 9, who had Ebstein's anomaly, a pathway with a
short anterograde effective refractory period --.as success-
fully ablated, but a second pathway with a long refractory
period could not be ablated at the same session .
Accessory pathway conduction returned after initially
succ~,ssfnl ablation in four patients . A second ablation pro-
c , -dure was successful in two patients and not attempted in
two. One of the latter, Patient I I with Shone's complex, had
recurrence of pre-excitation without tachycardia 48 h after
the initial procedure, and supraventricular tachycardia was
not inducible at repeat electrophysiologic study by the
esophageal route . Patient 2, the other patient with recur-
rence of pre-excitation, is described in the following section .
Patients I and 2 subsequently underwent uncomplicated
reparative or palliative procedures with a cardiopulmonary
bypass duration of IS min in both cases . Patient 3 has been
accepted for a Fontan procedure but has not yet undergone
surgery . Neither patient experienced intraoperative or im-
mediate postoperative supraventricular t zhycardia . Patient
2 had a recurrence of pre-excitation 3 days postoperatively
with a single short episode of supraventricular tachycardia .
She is currently receiving propranolol and has no tachycar-
dia. Her condition is considered improved because the
arrhythmia was not controlled with this or any other medi-
cation before the ablation procedure .
Patient 4 had cardiomyopathy with severe progressive
left ventricular dysfunction unrelated to the
Wolf-
Parkinson-Whiff, syndrome or tachycardia . The patient had
.i recurrence ol,* pre-excitation the evening after the first
procedure and the following day had a second procedure that
was successful. He had no episodes of tachycardia after
ablation and underwent heart transplantation I month later .
Examination of the heart revealed a discrete, well demar-
cated radiofrequency lesion at the tricuspid annulus .
Technical considerations . In five of the seven patients
with Ebstein's anomaly, mapping of retrograde atria] activa-
tion during supraventricular tachycardia and anterograde
ventricular activation during sinus rhythm was performed
using a mapping wire inserted into the right coronary artery
(custom device, Viggo-Spectramed) . Right coronary artery
mapping allowed precise localization of the accessory path-
ways and more rapid evaluation in the presence of multiple
886
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Table 1 .
Raaiofrequency Ablation of Arrhythmias With Congenital Substrate
Pt Age tyr)/
No,
Gender Cardiac Anomalies
D/M Ebstein's anomaly,
ASD
2
21F Pulmonary atresia,
hypoplasfic RV, B-T
shunt
3 2"t Ebstein's anomaly,
hypoplastio RV,
Ports anastomasis
4 610V Ebstein's anomaly,
severe LV
fts ."%cdon
5
l6/M ribstein'% anomaly
G BRIM Small to moderate
VSD
7 131F transposition, VS1
8 8/F Ebstein's anomaly
9
I 5/m
Ebstein's anomaly,
ASD
Severe Ebstein's
anomaly, patent
foramen ovate and
right to left shunt
Parachute initial valve,
supravalvar mitral
ring, sip coarctation
and +/p Anomalous
to coronary
rcimptomakii
Ant - antcvior ; AS!) -
atrial septal detect: AV m AVNRT - attioventricular node reentrant tachycardia ; U-T = flialock-Taussig, ERP =
e8eetive reftactowy period ; F ~ female-, Fluoro - fluoroscopic ; Lai lateral ; Lt = left ; LV = left ventricular . M = mole -. MA = not available ; Post =
posterior ;
Post
.Lat
- post lateral; PostSept - posterosepial . lit 4b right ; RV cot ventri0c
; sip = status post ; SVT = supraventricular tachycardia ; VSD = ventricular
ups 660.
10 32jM
I I l/M
pathways, as well as the plane of the AV groove in these
patients with Ebstein's anomaly . This was particularly im-
portant in Patient 3, who had severe right, ventricular hypo-
plasia (Fig, 1). Patient 4 had undergone a diagnostic electro-
physiologic study several years earlier and was thought to
have two free wall pathways, anterior and posterior, when
mapping was performed by conventiopal means using a
catheter rotated through 36O . However, right coronary
artery mapping at the time of the ablation demonstrated a
single right lateral pathway . fit each patient with Ebstein's
anomaly, the pathways were approached with an ablation
catheter passed from the inferior vena cava . Because of the
inferior displacement of the tricuspid valve leaflets into the
ventricle, positioning of the catheter tip under the valve
leaflet would not have been useful, Therefore, the ablation
catheter was positioned against the AV ring either directly or
after flexion of IW
. Particular attention was paid to obtain-
JACC Vat. 22. No . 3
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Comments
2 sessions, ASD closure
after ablation
Had B-T shunt and
tricuspid avulsion
To undergo Fontan
procedure
2 sessions . Had heart
transplantation I Innn
later
2 sessions
Moderate LV
enlargement due to
VSD
AVNRT not approached
2 sessions
Short ERP pathway
ablated
Now controlled on
medication
Slow pathway ablation
also performed. Pre-
excitaiion without
SVT recurred at 4S h .
SVT not inducible at
restudy
ing a catheter position with equal atria] and ventricular
electrogram amplitudes to avoid administering energy in the
atrialized right ventricle .
The congenital heart disease in Patients 2, 3, 7 and I I
added significant technical difficulties to the ablation proce-
dure . Patient 7 had ventricular inversion with L-transposition
of the great arteries ; therefore the ablation of a left posterior
paraseptal pathway required positioning of the ablation
catheter on or under a left-sided tricuspid valve . The ven-
tricular septum was in a sagittal rather than an oblique plane,
thereby complicating catheter manipulation . Initially a
patent foramen ovate was crossed, but ablation attempts on
the atrial side failed to eliminate pre-excitation . Subse-
quently, the pathway was s,,_tci;essftjRy ablated by the retro-
grade route . Patient 11, who had Shone's complex with
aortic stenosis, a stenotic small parachute mitral valve and a
stenosing supravalvar mitral ring, had previously undergone
Accessory Pathway
Locations
Initial
Success
Fluoro
Time
(min)
Follow-Up
(mo)
Clinical Status
at Follow-Up
Rt PostLat Yes 90.2
31 No recurrence
mot
Rt PostLat
Yes
Yes 55 .7 24 Recurrence,
Rt Lat
Yes 40.0 22
improved
No recurrence
Rt Lot
Rt Ant
Yes
Yes
NIA
60.4
I
23
No recurrence
No recurrence
Rt Ls,
Rt Po'll
Lt Lot
Yes
Yes
Yes
NA 21 No recurrence
Lt Post (with Yes 131 .5
19 No recurrence
AVNRT)
Rt PostLat Yes 68 .5 13
No recurrence
Rt Lot Yes 144 13 No recurrence
Rt Post
Rt Post
No
No 124 10 Not improved
Lt Post wraseptal Yes 95 .3 Recurrence,
(with dual AV improved
node pathways)
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Table 2
. Radiofrequency Ablation of Arrhythrnias With Acquired Substrate (inn
-aanial ire
Ablation Site
Success
Alriolomy site
	
Yes
(Lat RA)
Between CS and
Yes
tricuspid ring
RA between conduit
Yes
and tricuspid sing
Aldotomy site, ASD
Yes
patch
CS = uwmry lianas ; RA = right MUW other abbreviations as in Table 1 .
repair of aortic coarctation and reimplantation of an anom-
alous left coronary artery that arose from the pI6ionary
artery . These anatomic factors necessitated a irimsseptal
rather than a retrograde approach ton left posterior parasep-
tal pathway . The patient also had dual AV node pathways,
and slow pathway modification was also successfully per-
formed .
Group 2
Patients . Four patients underwent catheter ablation of
intraatrial reentrant tachycardias that were considered se-
quelae of atrial surgery (Table 2) . Two patients had under-
gone patch closure of secundum atrial septal defects, one
had undergone a modified Fontan procedure, and one with
single ventricle and D-transposition had undergone a pallia-
tive Mustard procedure to decrease cyanosis . The atrial
cycle lengths during intraatrial reentrant tachycardia ranged
from 310 to 430 ms. In Patient 13, who had had the Fontan
operation, tachycardia was associated with the rapid devel-
opment of marked hepatomegaly . In Patients 12 to 14, atrial
flutter was inducible only by aggressive atrial stimulation
and was not present clinically .
Results . All four patients had initially successful radio-
frequency ablation, with noninducibility of the previously
easily inducible atrial tachycardia . Patient 12 had a single
recurrence of atrial tachycardia at a slightly longer atrial
cycle length and with a different P wave axis and morphol-
ogy, suggesting a second circuit . This has not recurred .
Patient 14 had a recurrence of atria] tachycardia with a
similar P wave morphology and axis 3 months after the
procedure, but at a markedly longer cyclee length (415 ms vs .
330 ms before ablation) and has been completely asymptom-
atic without hepatomegaly despite continued tachycardia .
Technical considerations . In the two patients who had
had atrial septal defect repair, positioning of diagnostic
catheters was routine, and left-sided signals were obtained
from the coronary sinus . In the patient with the Fontan
procedure (Patient 14), left atrial recordings were not ob-
tained because no attial communication existed and the
VAN HARE CT AL,
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a
tachycardia/
Clinical Status
?t Follow-Up
Comments
Recurrence,
One recurrence with
improved
different P axis
No i -ecurrence Attial flutter also present
but was not approached
Recurrence,
Recurrence at significantly
improved
slower atrial rate, well
tolerated
No recurrence
Two distinct forms of
Wraaffial reentry ablated
coronary sinus had been left to drain into the left atrium . In
the patient with a Mustard procedure and single ventricle,
the coronary sinus was entered directly from the inferior
vena cava, The pulmonary venous atrium was reached by
passing a catheter from the inferior vena cava through the
baffle into the left ventricle and subsequently backward across
the other AV valve into the pulmonary venous atrium .
In Patients 12 and 15, a site of early atrial activation
during tachycardia was found at the lateral right atrium at the
probable site of atriotomy, with fractionation of the local
electrograms . Application of radiofrequency energy at this
site during tachycardia caused termination
of the tachycar-
dia, and it could not be reinduced . In addition, Patient 15 had
a second discrete substrate for intraatrial reer trant tachycar-
dia with eAy atrial activation and fractionation in the region
of the atrial septal defect patch, which was similarly ablated,
as well as AV node reentry, which was eliminated by
ablation of the slow pathway .
In Patient 13, intraatrial rerewa,a tachycardia could be
induced only from the pulmonary venous atrium, but very
early atrial electrograms with fractionation were found at the
posterior right AV ring just beneath the mouth of the
coronary sinus . Application of radiofrequency energy at this
site during tachycardia terminated the rhythm, and it could
not be reinduced .
In Patient 14, early atrial activation during intraatrial
reentrant tachycardia was found close to the right AV
groove anterolaterally, with fractionated electrograms found
at the isthmus formed between the hypoplastic tricuspid
annulus and the origin of the conduit, which connected the
right atrium to the pulmonary artery (Fig . 2) . Application of
radiofrequency energy at this site caused termination of
tachycardia, and it could not be reinduced .
Discussion
Congenital and acquired arrhythmia substrates . The as-
sociation of supraventricular arrhythmias and congenital
heart disease may have either a congenital substrate, such as
IVW lff-Parkinson-White syndrome, or a surgically acquired
No .
Age
(yr)
Cardiac Anomalies
12
81M
sip ASD
13 17/1' D-transposition, single
14 7/F
ventricle, pulmonary
valve stenosis . sip
Mustard procedure
Tricuspid hypoplasia,
15 29/F
sip Fontan
procedure
s/1) ASD
Fluoroscopic
Time (An I
Foliow-L'p
imo)
33 .2 13
62 .5 io
45 .1
7
113 4
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MAWQVh
-
RA I"Id
111A twoNow
RA flOOMNSM -)
RA flaWMarlor -
I
RA .he
100 me
F" 2. Intracardiac electrograms obtained in Patient 13 during
intraatrial reentrawn tacl'ycardia . Surface P waves are best seen in
lead 11 and are marked with arrows and the letter P. Note variable
atrioventricular conduction, electrogram fractionation recorded at
the successful ablation site and recording of atrial activity at this site
well in advance of the surface P wave . tat = lateral ; mid = middle ;
RA - right atrium .
substrate, particularly after atrial surgery . The congenital
substrate for arrhythmia is not rare . Of patients with Wolff-
Parkinson-White syndrome followed up from birth, 20%% to
37% have associated congenital heart disease (18-21) . Con-
versely, of patients with Ebsteiri's anomaly of the tricuspid
valve, as many as 26% will have accessory pathways, and
these are often multiple (22-24) . Acquired substrates for
arrhythmias may be the result of atrial dilation, atrial sutur-
ing or scar, or both, or injury to the conduction system .
Consequently, patients undergoing cardiac surgery are at
risk of developing new cardiac arrhythmias, and these may
cause significant morbidity and mortality . The latter is of
particular concern in patients who have undergone a Mus-
tard or Senning procedure for D-transposition and those with
the Fontan procedure (or its modifications) for various forms
of functional single ventricle . These patients are known to be
at risk of sudden cardiac death, and it has been suggested
that the mechanism is rapid conduction of atrial arrhythmias
to the ventricle (25,26) .
Because of associated hemodynamic abnormality, pa-
tierts with structural heart disease may tolerate tachycardias
more poorly than patients with a structurally normal heart .
In view of this and the often abnormal conduction system of
postoperative patients, the risks of antiarrhythmic agents are
likely to be higher in this group. Most available antiarrhyth-
mic agents are known to exacerbate sinus node
dysfunction,
a common problem in patients after extensive atrial surgery,
and the possibility of such
exacerbation often requires
implantation of permanent pacemakers in these patients (27).
JACC Vol. 22, No . 3
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Agents such as quinidine and flecainide have an increased
proarrhythmic potential in patients with ventricular dysfunc-
tion (28-30) and should be avoided . Finally, most antiar-
rhythmic agents cause or exacerbate systemic ventricular
dysfunction (31), a problem of particular concern in patients
after the Fontan procedure . For all these reasons, radiofre-
quency ablation deserves careful consideration in the man-
agement of arrhythmias in patients with congenital heart
disease .
Technical considerations. The use of transcatheter radio-
frequency techniques in this patient group requires a thor-
ough knowledge of such techniques in patients with a
structurally normal heart, a knowledge of congenital heart
disease and experience with the catheterization of patients
with congenital and other structural heart defects, and the
ability to improvise and adapt techniques for the particular
situation encountered . Coexisting defects may limit the
options for catheter approach, as in Patient I I with coarcta-
tion and mitral stenosis, and therefore may require the use -""
transseptal puncture in small patients . Such defects may also
direct the placement of the ablation catheter, as in Patient 14
with intraatrial reentrant tachycardia involving the Fontan
conduit . There is a clear advantage to performing a diagnos-
tic cardiac catheterization at the time of electrophysiologic
study with catheter ablation in preparation for cardiac sur-
gery, because it minimizes the frequency of vascular entry in
these patients .
Despite the difficulties inherent in performing ablation
procedures in patients with serious structural heart disease,
10 of the 15 patients reported here had complete elimination
of tachycardia and 14 of 15 had clinical improvement .
Although not as completely successful as our experience in
children without structural heart disease (7), these early
results indicate that radiofrequency ablation is a highly
effective alternative to surgery or lifelong antiarrhythmic
medication, or both, in this patient group .
Risks of ablation therapy In children . No major or minor
complications were evident either initially or at follow-up in
any of the patients in this report. Studies from individual
centers and one multicenter study (7,8,10,32,33) have shown
that the short-term risk of complications is quite low . The
long-term risks have yet to be determined. These risks could
conceivably include arrhythmias or coronary artery prob-
lems. Of some concern also is the exposure to ionizing
radiation that accompanies an ablation procedure . The
amount of exposure to the patient is similar to that received
during other interventional or even diagnostic catheteriza-
tions. One report (34) estimated the lifetime risk of a fatal
malignancy from a typical catheter ablation procedure in an
adult as 0.07%. This risk may be higher in children because
of longer life expectancy, and efforts to reduce the radiation
exposure associated with radiofrequency ablation are
needed .
Ablation as preparation for head surgery
. Patients with
abnormal tachycardia who are to be referred for surgical
correction or palliation of a structural heart defect represent
JACC Vol . 22, No . 3
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a special problem . In the past, several approaches have been
available :
1) Patients may undergo surgical division of an accessory
pathway at the time of the other operation (3) . If this
procedure is performed by the endocardial approach, it adds
significantly to the duration of cardiopulmonary bypass and
perhaps might increase the risk of the operation as a whole
(35,36) . A major perioperative neurologic complication has
been reported in at least one such patient (3) . Either ablation
by the epicardial approach (37) or radiofrequency ablation
before surgery would seem a lower risk approach ; the bitter
is certainly more convenient because it frees the surgeon
from the need to ablate the pathway as part of an already
complex procedure .
2) The patient might undergo surgical correction without
an attempt at accessory pathway division . Theoretically,
postoperative tachycardia can be converted repeatedly by
programmed stimulation using epicardial pacing wires . How-
ever, endogenous or exogenous catecholamines may bring
about nearly incessant tachycardia, which may be very
poorly tolerated in the immediate postoperative period . We
(38) have observed two such patients before the advent of
radiofrequency techniques, both of whom did quite poorly
postoperatively, and others (21) have reported similar expe-
riences . The advantage of preoperative radiofrequency ab-
lation is that the potential for abnormal tachycardia due to
the accessory pathway is eliminated before surgery, simpli-
fying the operative procedure and lowering the risk .
Atria] tachycardia. Ectopic (automatic focus) atrial
tachycardia has been successfully approached by transcath-
eter techniques (32,39), and there is increasing experience
with the ablation of intraatrial reentrant tachycardia by these
means. Some investigators have had encouraging results in
adults with atrial flutter and an otherwise normal heart, but
there has been a significant recurrence rate of tachycardia
(39) . In general, reentrant rhythms require an area of slow
conduction, as well as an area of unidirectional block (which
may be an anatomic or functional harrier), for their initiation
and maintenance . Some patients who have undergone atrial
surgery could conceivably have a surgically created sub-
strate for intritatrial reentrant tachycardia because suture
lines may create barriers to transmission of cardiac conduc-
tion (40), protecting a zone of myocardium that then be-
comes available for participation in a reentrant circuit . In
Patient 14, for example, the conduit probably acted as a
barrier, protecting an isthmus of tissue between the conduit
and the tricuspid valve ring that, in turn, acted as the
substrate for intraatrial reentrant tachycardia . Future work
in this area should focus on a careful study of the possible
barriers to conduction created by different forms of cardiac
surgery, as well as application of these techniques to patients
with atrial flutter .
Conclusions. We have found transcatheter techniques
using radiofrequency energy to be effective in the definitive
treatment of patients with structural heart disease and tachy-
cardia due either to the Wolff-Parkinson-White syndrome or
VAN HARE ET AL .
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to intrawnial reergiry . The use of these techniques in this
patient group requires a thorough knowledge of cardiac
catheterization techniques in patients with congenital and
other structural heart disease . In patients who are to undergo
surgical correction or palliation, preoperative ablation of the
substrate for tachycardia is effective and may be preferred to
operative accessory pathway division. The ablation of in-
traatrial reentrant tachycardia shows promise in the manage-
ment of patients who have undergone extensive atrial sur-
gery; it may eventually become the preferred approach,
particularly when there are contraindications to the use of
antiarrhythmic agents .
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